KR20150014033A - Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method - Google Patents

Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method Download PDF

Info

Publication number
KR20150014033A
KR20150014033A KR1020130088704A KR20130088704A KR20150014033A KR 20150014033 A KR20150014033 A KR 20150014033A KR 1020130088704 A KR1020130088704 A KR 1020130088704A KR 20130088704 A KR20130088704 A KR 20130088704A KR 20150014033 A KR20150014033 A KR 20150014033A
Authority
KR
South Korea
Prior art keywords
cmwe
cells
cell
chang
pupa
Prior art date
Application number
KR1020130088704A
Other languages
Korean (ko)
Inventor
김태웅
성재모
박형진
조재열
박영철
성기호
Original Assignee
강원대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강원대학교산학협력단 filed Critical 강원대학교산학협력단
Priority to KR1020130088704A priority Critical patent/KR20150014033A/en
Publication of KR20150014033A publication Critical patent/KR20150014033A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • A61K36/068Cordyceps
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to an inhibition effect of a water extract of Cordyceps militaris (CMWE) which is a novel anti-cancer functional substance on hepatocellular carcinoma cells, which is investigated through various experiments. The present invention provides biopharmaceuticals as antitumor agents. A method for preparing the CMWE comprises the steps of: extracting and purifying a functional substance from Cordyceps militaris; cultivating human hepatoma cell line (HepG2) and human liver cell line (Chang) which is normal cells; treating the human liver cell line with hepatotoxicity inducing substance, cultivating the same, and measuring cell viability; analyzing using high performance liquid chromatography (HPLC); and analyzing using flow cytometry and performing western blotting to investigate biochemical mechanisms of protection effects of CMWE on liver cell damages.

Description

번데기동충하초 추출물을 유효성분으로 함유하는 간 기능 개선 기능성 식품조성물 및 그 제조방법 {Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method}TECHNICAL FIELD The present invention relates to a food composition for improving liver function and a method for producing the same,

본 발명은 번데기동충하초로부터 간기능을 향상시키는 물추출물의 효능효과에 관한 것이다.       The present invention relates to the efficacy of water extracts that enhance liver function from the pupae of Cordyceps sinensis.

번데기동충하초는 그 종류가 아주 다양한데 그중에서도 고치큰번데기동충하초는 땅 속에 있는 죽은 고치 속의 큰 번데기에서 발견되며, 여러 개의 자좌를 형성한다. 기주의 크기는 28~35mm X 21~26mm이며, 35~45mm 크기의 자좌는 주황색을 띤다. 곤봉형의 자좌는 진한 주황색을 띠고, 크기 20~30mm인 머리와 그것을 받쳐 주는 크기 18mm~12mm인 자루로 나누어지며, 경계가 명확하다. 머리에는 반 돌출형의 자낭각이 조밀하게 분포하며, 크기는 590~550um X 320~350um이다. 자낭은 390~425um이고, 실 모양의 자낭포자들이 존재한다. 자낭포자는 격막에 의하여 분리된 다수의 세포들로 이루어져 있으며, 원형의 2차포자로 발달하여 발아한다.The pupa of Cordyceps is very diverse, among which the cocoon, the large pupa, is found in the large pupa of the dead cocoon in the ground and forms several stools. The size of the host is 28 ~ 35mm X 21 ~ 26mm, and the size of 35 ~ 45mm is orange. The club head is divided into a dark orange color, a head of 20 ~ 30mm in size and a bag of 18 ~ 12mm in size to support it. The boundary is clear. The hair is densely distributed in the semitendinous shape, and the size is 590 ~ 550um X 320 ~ 350um. The acorns are 390 ~ 425 μm, and there are thread-shaped aspergillus spores. The ascospores are composed of a large number of cells separated by the septum and develop into a circular secondary spore and germinate.

곰팡이의 일종인 동충하초균은 주로 온습도가 높아지는 시기에 살아있는 곤충의 몸 속으로 들어가 발육증식하면서 기주(寄主) 곤충을 죽이고 얼마 후 자실체(字實體)를 곤충의 표피에 형성하는 일종의 약용버섯이다. 동충하초균의 생성은 온습도가 높아지는 계절 특히 여름철에 동충하초균의 포자가 비산하여 살아있는 곤충(알, 유충, 번데기, 성충태)의 몸에 부착하여 침입하면서부터 시작되는데 곤충의 호흡기, 소화기, 마디 등 침입하기 쉬운 부드러운 표피에 부착한 포자는 발아관(發芽管)을 내어 곤충의 몸안으로 들어가 영양분을 탈취하면서 수많은 균사가 증식되기 때문에 결국에는 기주 곤충은 죽게되며 미이라처럼 된다. 죽은 곤충을 보면 흰균핵으로 충만하며, 미이라로 된 곤충은 곤충형태를 그대로 유지하면서 월동한 후 적당한 온습도를 만나면 죽은 곤충의 몸에서 동충하초를 형성하게 되는 것이다. 이러한 과정을 되풀이하면서 동충하초는 생성, 번식을 계속하게 된다. 버섯의 길이는 동충하초의 종류에 따라 몇 mm에서 10cm이상 되며 버섯의 색깔도 황색으로 대단히 아름다운 자태를 가지고 있다. It is a kind of medicinal mushroom that grows into a living insect body at the time of high temperature and humidity mainly, and kills the host insect and grows a fruiting body on the insect epidermis. The generation of the Chinese cabbage fungus begins with the season when the temperature and humidity become high, especially when the spore of the Chinese cabbage fungus is scattered in the summer and it attaches to the body of living insects (egg, larva, pupa, adult fish) and enters the respiratory, digestive, The spores attached to the smooth skin, which is easy to grasp, take out the germ tube and enter into the body of the insect and take up the nutrients, and many mycelium grows, so the host insect is killed and becomes like a mummy. Dead insects are filled with white sclerotia, and insects with mummies form insects in the body of dead insects when exposed to moderate temperature and humidity after wintering while keeping the insect form intact. By repeating this process, Cordyceps is continuing to produce and propagate. The length of the mushroom is more than a few millimeters to 10 cm depending on the type of Cordyceps, and the color of the mushroom is also very yellow.

번데기 동충하초는 수분 10.84%, 지방 8.4%, 조단백 25.32%, 탄수화물 28.9%, 회분 4.1%로 구성되어 있으며, 지방 성분으로는 포화 지방산이 13%, 불포화 지방산이 82.2% 함유되어 있다. 비타민 B12는 100g당 0.29mg이 들어 있다. The pupa of Cordyceps sinensis is composed of 10.84% moisture, 8.4% fat, 25.32% crude protein, 28.9% carbohydrate and 4.1% ash, and the fat content is 13% saturated fatty acid and 82.2% unsaturated fatty acid. Vitamin B12 contains 0.29mg per 100g.

번데기동충하초에 함유된 유효성분인, 코디세핀 (cordycepin)은 3'-deoxyadenosine 이라하며, 1950년에 동충하초에서 발견되었으며, 번데기동충하초(Cordyceps militaris)와 박쥐나방동충하초(Cordyceps sinensis)에서만 발견된 물질이며, 항암, 항염, 항균작용이 있다는 것으로 알려지고 있다. Cordycepin, an active ingredient in the pupae Cordyceps, is 3'-deoxyadenosine, found in Cordyceps sinensis in 1950 and is found only in Cordyceps militaris and Cordyceps sinensis, It is known that there is anti-cancer, anti-inflammation and antibacterial activity.

그밖에, 다당류(polysaccharide, 항암, 항염, 항산화제, 면역증강제) 및 ergosterol (항암제) 등이 함유되어있는 것으로 알려지고 있다. In addition, polysaccharides (anticancer, anti-inflammatory, antioxidant, immunity enhancer) and ergosterol (anticancer) are known to contain.

그외에 동충하초에 약 7%정도 들어있는 코디세픽산은 D-mannitol란 물질로서 혈액 속에 들어가 순화하면서 머리의 내압을 내리고 또한 눈의 내압을 내리는 작용과 이뇨작용을 한다. 다당체는 질병으로부터 인체를 방어하는데 대단히 중요한 역할을 하는 물질로서 면역력을 증가시키고 심장과 간장을 지키며 암을 억제하거나 노화방지에 기여한다. 동충하초는 예전부터 귀중한, 장수, 강장의 신비의 비약으로 문헌에 보면 폐를 보호하고 신장을 튼튼하게 하며 지혈을 막고 담을 식히고 기침을 멎게 한다는 기록과 면역력증강, 염증억제, 등과 같이 자연치유력을 높이는 효능이 있다고 기록되어 있다.In addition, Cordisepic acid, which contains about 7% of cordyceps, is a substance called D-mannitol, which enters the blood and purifies the head while reducing the internal pressure of the head and diuretic action. Polysaccharides play a very important role in defending the human body from diseases. They increase immunity, protect the heart and liver, inhibit cancer, and contribute to anti-aging. Cordyceps is a precious, long-lived and long-lasting mysterious drug in the literature, which protects the lungs, strengthens the kidneys, prevents hemostasis, coolens the follicles and stops coughing, enhances the natural healing power like immunity and inflammation suppression. .

이와 같이 동충하초(Cordyceps militaris)는 매우 다양한 약리작용을 가지고 있는데 열거하여 보면 다음과 같다. 동충하초는 체력을 증강시킴으로서 감기, 만성 기침, 천식, 발작, 빈혈, 허약, 남성의 성적 기능 장애, 고혈압 등에 좋은 치료력을 나타내며, 피로 회복에도 탁월한 효과를 나타낸다. Thus, Cordyceps militaris has a wide variety of pharmacological actions. Cordyceps is shown to have good therapeutic power against cold, chronic cough, asthma, seizures, anemia, weakness, male sexual dysfunction and hypertension by enhancing physical strength and shows excellent effect for fatigue recovery .

또한, 항균작용이 있어 결핵균, 폐렴구균, 저출혈성패혈증간균, 석고양소아포균(石膏樣小芽 胞菌), 탄저간균, 비저간균(鼻疽杆菌) 등에 대한 억제작용이 있다.In addition, it has antimicrobial action and has an inhibitory action against Mycobacterium tuberculosis, Streptococcus pneumoniae, Low hemorrhagic septicemia bacillus, Gypsum gypsum bacterium, Ganoderma lucidum, and Bacillus thuringiensis.

동충하초의 약리작용 중에서 흥미를 끌고 있는것 중의 하나가 항암작용이다. 최근 일본의 동북대학과 동북 약학대학의 공동연구 결과를 보면 동충하초는 분명히 항암작용이 있음을 알 수 있다. 이에 따르면 암에 걸린 마우스(실험쥐)의 뱃속에 동충하초(벌 동충하초) 추출물을 5일간 매일 1번씩 주사 후의 암세포가 24로 현저히 줄어든다고 보고하고 있다. 바꾸어 말하면 동충하초는 암세포의 증식을 76%정도 억제하는 작용이 있음을 나타내고 있는 것이다.  Among the pharmacological actions of Cordyceps, one of the interesting things is anticancer action. Recently, the results of joint research between Tohoku University and Toho University of Pharmacy in Japan show that Cordyceps sinensis has an anticancer effect. According to this report, it is reported that the number of cancer cells after injection of Cordyceps (Bee Cordyhakho) extract once every day for 5 days is decreased to 24 in the stomach of cancer mouse (experimental rat). In other words, it shows that Cordyceps sinensis inhibits the proliferation of cancer cells by about 76%.

동충하초의 약리작용 중 항암 성분을 살펴보면 항암 효과를 나타낸 씨의 성분은 동충하초의 성장 도중에서 만들어지고 이 성분은 전혀 부작용이 없고 저항력 증강, 세균이나 바이러스 감염에 뛰어난 작용을 나타낸다. 그것은 암세포 자체의 억제와 번식 속도를 억제하는 효과를 의미하므로 암환자에게는 획기적인 발견이다. Among the pharmacological effects of Chinese caterpillar fungus, the anti-cancer component of the seeds is produced during the growth of Chinese caterpillar fungus, and it has no side effects at all and shows excellent resistance against bacterial or viral infection. It is a breakthrough discovery for cancer patients because it means suppression of cancer cells themselves and suppression of reproductive rate.

최근 국내에서는, 농촌진흥청과 서울대 천연물 과학연구소 공동으로 약리효과를 검색한 결과 항암작용과 면역증강, 항피로 작용 등이 탁월한 것으로 밝혀졌다. 복수 암에 걸린 쥐에 이 동충하초 추출물을 15일간 복강 내에 투여한 결과 쥐의 생존일수가 36일로서 대조군(17.8일)에 비해 202.6%의 수명연장 효과를 나타냈다. 현재 임상에서 항암제로 쓰이고 있는 크레스틴보다도 1.5배정도 더 높은 항암효과를 나타냈다. 또, 고형암을 유발하는 쥐의 경우 암세포 억제율이 84%에 이르렀다고 한다. 이 동충하초 추출물을 쥐의 복강 내에 3일간 투여한 후 면역증강효과를 검색한 결과 매우 강력한 식세포 활성화 증강효과가 발견되었음을 확인했다. 특히, 면역부활제 또는 항암제로 쓰고 있는 자이모산 보다도 약 2배의 강력한 면역 증강 효과를 나타냈다. 최근 보고에 따르면 천연물이 포함하고 있는 여러 물질들 중 항암효과들이 많은 연구와 실험들에 의해 증명되고 있는 가운데 천연물이란 현대인들에게 인위적인 것이 아닌 자연에서 얻어진 물질들로 인해 더욱 안정적이고 믿을 수 있는 물질로써 다가가고 최근에는 의학 재료뿐 아니라 음식과 화장품 등 모든 방면에서 천연물질들의 사용이 증가하는 추세이다.
Recently, in Korea, RDA and SNU research institute jointly investigated pharmacological effects, and it was found out that the anticancer effect, immunity enhancement and anti-fatigue action were excellent. The survival days of the mice were 36 days, which was 202.6% longer than that of the control group (17.8 days). The anticancer effect was 1.5 times higher than that of cresstine, which is currently being used as an anticancer drug in clinical practice. In addition, the rate of cancer cell suppression in solid cancer-induced rats was 84%. The extracts of Cordyceps mellifera were administered in the abdominal cavity of rats for 3 days, and the results of immune enhancement were found to be very strong. In particular, it showed about two times stronger immunity enhancement than Zymosan used as an immunostimulating or anticancer drug. According to a recent report, anticancer effects among various substances contained in natural products have been proved by many studies and experiments. Natural products are more reliable and reliable materials due to the substances obtained from nature, not artificial to modern people. In recent years, the use of natural materials has increased in all aspects of medicine, as well as food and cosmetics.

대한민국 공개특허 제 10-2013-0040655 호에는 곤충 글라이코사미노글리칸의 신규 용도에 관한 것으로 보다 곤충에서 유래한 곤충 글라이코사미노글리칸을 유효성분으로 포함하는 지방간 예방 및 치료용 조성물, 및 고지혈증 예방 또는 치료용 조성물에 관한 것이며 곤충 글라이코사미노글리칸은 지방간 또는 고지혈증의 예방, 치료/개선의 목적으로 사용할 수 있다. 글라이코사미노글리칸은 새로운 지방간 또는 고지혈증의 치료제의 개발에 유용하게 이용될 수 있는 효과를 나타낸다고 개시된 바 있다.         Korean Patent Laid-Open Publication No. 10-2013-0040655 relates to a novel use of insect glycosaminoglycan, and more particularly relates to a composition for prevention and treatment of fatty liver comprising an insect glycosaminoglycan derived from an insect as an active ingredient, The present invention relates to a composition for preventing or treating hyperlipemia, and the insect glycosaminoglycan can be used for the purpose of prevention or treatment / improvement of fatty liver or hyperlipemia. It has been disclosed that glycosaminoglycan exhibits an effect that can be advantageously used in the development of a therapeutic agent for a new fatty liver or hyperlipemia.

그러나 상기 특허문헌 어디에도 번데기동충하초 물추출물이 간기능보호에 기여한다는 내용에 대하여는 전혀 암시되거나 개시된 바 없다.
However, none of the above-mentioned patent documents suggest or suggest that the water extract of Cordyceps sinensis extracts contributes to protection of liver function.

따라서, 본 발명의 목적은 번데기 동충하초로부터 간기능을 향상시키는 기능성 물질을 추출하고 정제하는 데 있다.      Accordingly, an object of the present invention is to extract and purify a functional substance that enhances liver function from a pupa of Cordyceps sinensis.

본 발명의 다른 목적은 번데기 동충하초 물추출물(Water extract of Cordyceps militaris,CMWE)의 간보호 효과를 제공하는데 있다.
Another object of the present invention is to provide a liver protecting effect of Water extract of Cordyceps militaris (CMWE).

본 발명의 상기 목적은 번데기 동충하초로부터의 기능성 물질을 추출하고 정제하는 단계와; 사람의 간암세포인 HepG2(Human hepatoma cell line)와 정상세포인 Chang(Human liver cell line)을 배양하는 단계와; 사람의 정상세포에 간독성 유발물질을 처리한 후 배양하여 cell viability 정도를 측정하는 단계와; High performance liquid chromatography(HPLC) 분석하는 단계와; 간세포 손상에 대한 보호 효능의 생화학적 기전 규명을 위한 Flow cytometry 분석과 Western blotting을 수행하는 단계를 통하여 달성하였다. The above object of the present invention is achieved by a method for extracting and purifying a functional substance from a pupa of Cordyceps sinensis; Culturing HepG2 (Human hepatoma cell line) and Chang (Human liver cell line) which are normal cells; Measuring cell viability by treating human normal cells with a hepatotoxic agent; High performance liquid chromatography (HPLC); Flow cytometry analysis and Western blotting were performed to identify the biochemical mechanism of protective effect against hepatocyte injury.

본 발명에 따른 번데기동충하초 물추출물(Water extract of Cordyceps militaris,CMWE)은 간암세포를 억제시키고 간을 보호하는 뛰어난 효과가 있으므로 생물의약산업상 매우 유용한 발명인 것이다.The water extract of Cordyceps militaris (CMWE) according to the present invention is an extremely useful invention in the biopharmaceutical industry because it has an excellent effect of inhibiting liver cancer cells and protecting the liver.

도 1은 HPLC에 의한 번데기동충하초 추출물 CMWE의 특성을 나타낸 그래프이다.
도 2는 번데기동충하초에서 추출한 CMWE에 함유된 cordycepin 및 adenosine의 함량을 나타낸 그래프이다.
도 3은 순수한 adenosine 및 cordycepin 의 standard curve를 나타낸 그래프이다.
도 4는 Chang cell (normal)에 대한 CMWE의 효과를 나타낸 그래프이다.
도 5는 HepG2(cancer cell)에 대한 CMWE의 효과를 나타낸 그래프이다.
도 6은 여러 SNP(sodium Nitroprusside) 농도에 따른 간세포(Chang cell)손상을 나타낸 그래프이다.
도 7은 여러 SNP(sodium Nitroprusside) 농도에 따른 간세포(Chang cell)의 손상율을 계산하여 나타낸 그래프이다.
도 8은 600uM의 SNP에서 간세포(Chang cell)의 손상율을 나타낸 그래프이다.
도 9는 여러 ethanol 농도에 따른 간세포(Chang cell) 손상을 나타낸 그래프이다.
도 10은 여러 SNP 농도에 따른 간세포(Chang cell) 손상율의 계산 결과를 나타낸 그래프이다.
도 11은 500uM의 ethanol 에서 간세포(Chang cell)의 손상율을 나타낸 그래프이다.
도 12는 여러 AAP(Acetaminophen) 농도에 따른 간세포(Chang cell) 손상을 나타낸 그래프이다.
도 13은 여러 AAP(Acetaminophen) 농도에 따른 간세포(Chang cell) 손상율을 계산하여 나타낸 그래프이다.
도 14는 7.5uM의 AAP에서 간세포(Chang cell) 손상율을 나타낸 그래프이다.
도 15는 15uM의 AAP에서 간세포(Chang cell)의 손상율을 나타낸 그래프이다.
도 16은 Chang cell(normal)에 대한 CMWE의 효과를 나타낸 그래프이다.
도 17은 Chang cell(normal)에 저해제인 AAP를 처리하였을 때, CMWE의 보호효과를 나타낸 그래프이다.
도 18은 Chang cell(normal)에 저해제인 SNP를 처리하였을 때, CMWE의 보호효과를 나타낸 그래프이다.
도 19는 번데기동충하초 추출물(CMWE) 및 7mM AAP를 처리한 Chang liver cell에서 propidium iodide 염색법을 이용한 Flow cytometry의 분석 결과를 나타낸 그래프이다.
도 20은 번데기동충하초 추출물이 AAP를 처리한 Chang liver cell의 세포주기에 미치는 영향을 나타낸 그래프이다.
도 21은 번데기동충하초 추출물(CMWE)이 PARP의 활성에 미치는 영향을 나타낸 그래프이다.
도 22는 번데기동충하초 추출물(CMWE)이 ERK 활성에 미치는 영향을 나타낸 그래프이다.
도 23은 번데기동충하초 추출물(CMWE)이 JNK 및 p38 활성에 미치는 영향을 나타낸 그래프이다.
FIG. 1 is a graph showing the characteristics of the CMWE extract of Cordyceps sinensis extract by HPLC.
FIG. 2 is a graph showing the content of cordycepin and adenosine contained in CMWE extracted from the pupa of Cordyceps sinensis.
Figure 3 is a graph showing the standard curves of pure adenosine and cordycepin.
4 is a graph showing the effect of CMWE on Chang cell (normal).
5 is a graph showing the effect of CMWE on HepG2 (cancer cell).
FIG. 6 is a graph showing damage of hepatocyte (Chang cell) according to various SNP (sodium nitroprusside) concentrations.
7 is a graph showing damage rates of hepatocytes (Chang cells) according to various SNP (sodium nitroprusside) concentrations.
8 is a graph showing damage rates of hepatocytes (Chang cells) at a SNP of 600 uM.
FIG. 9 is a graph showing damage of hepatocyte (Chang cell) according to various ethanol concentrations.
FIG. 10 is a graph showing the calculation results of hepatocyte injury rate according to various SNP concentrations. FIG.
11 is a graph showing damage rates of hepatocytes (Chang cells) at 500 uM ethanol.
12 is a graph showing damage of liver cells according to various AAP (Acetaminophen) concentrations.
FIG. 13 is a graph showing damage rates of hepatocytes (Chang cells) according to various AAP (Acetaminophen) concentrations.
14 is a graph showing damage rates of hepatocytes (Chang cells) in 7.5 uM AAP.
15 is a graph showing damage rates of hepatocyte (Chang cell) in AAP of 15 uM.
16 is a graph showing the effect of CMWE on Chang cell (normal).
17 is a graph showing the protective effect of CMWE when Chang cell (normal) is treated with an inhibitor AAP.
18 is a graph showing the protective effect of CMWE when the inhibitor SNP is treated in Chang cell (normal).
19 is a graph showing the results of analysis of flow cytometry using a propidium iodide staining method in a Chang liver cell treated with a pupa extract (CMWE) and 7 mM AAP.
20 is a graph showing the effect of the extract of Cordyceps sinensis extract on cell cycle of Chang liver cells treated with AAP.
21 is a graph showing the effect of the pupae extract (CMWE) on the activity of PARP.
FIG. 22 is a graph showing the effect of the pupae extract (CMWE) on ERK activity.
23 is a graph showing the effect of the pupae extract (CMWE) on the activity of JNK and p38.

이하에서는, 본 발명의 구성을 실시 예를 들어 더욱 상세히 설명하지만,Hereinafter, the configuration of the present invention will be described in more detail by way of examples,

본 발명의 권리범위가 이들 실시예에만 제한되지 않음은 자명하다.
It is to be understood that the scope of the present invention is not limited to these embodiments.

<< 실시예Example 1>  1> 번데기동충하초로부터From Pupae Cordyceps 기능성 물질의 추출 및 정제 Extraction and purification of functional materials

건조한 번데기동충하초 100g을 증류수 1L에 넣고 초음파로 분쇄한 다음 100℃에서 3시간 끓이는 과정을 2회 반복한다. 추출액을 Whatman 2 여과지로 여과 후 rotary evaporator(52℃)에서 1L로 감량하시킨 추출액에 2배 용량의 냉 94% 주정(-20℃)을 혼합하고 -20℃에서 하룻밤 방치한 후 원심분리하여 침전물을 회수한 후 증류수 200mL에 용해한 다음 동결건조한다(CMWE).100 g of the dried pupa of Cordyceps sinensis was added to 1 L of distilled water, ground by ultrasonication, and boiled at 100 ° C for 3 hours. The extract was filtered through a Whatman 2 filter paper, and then the volume was reduced to 1 L in a rotary evaporator (52 ° C.). The extract was mixed with 2 × volume of cold 94% alcohol (-20 ° C.), left at -20 ° C. overnight, And then lyophilized in 200 mL of distilled water (CMWE).

실험결과, 도 1에서 보는 바와 같이 HPLC를 사용하여 260nm에서 측정하였을 때 8~10분 사이에서 여러 Peak가 나타났으므로 상당히 Polar한 성분을 함유하고 있다는 것을 확인하였고 HPLC 분석 패턴 결과, CMWE가 생리활성물질인 Cordycepin을 함유하고 있다는 것도 확인할 수 있었다. As shown in FIG. 1, when HPLC was used at 260 nm, several peaks were observed in 8 to 10 minutes. Therefore, it was confirmed that Polar was contained in a considerable amount, and as a result of HPLC analysis, CMWE exhibited physiological activity It was confirmed that it contains Cordycepin, a substance.

또한, HPLC를 사용하여 CMWE의 구조적 특성 및 CMWE에 Cordycepin 및 adenosine이 함유되었는지를 조사한 결과 CMWE는 3~10분에서 여러 Peak들이 나타났기 때문에 CMWE는 Cordycepin 및 adenosine을 모두 함유하고 있다고 확인되었다(도 2). CMWE 중에 함유되어 있는 Cordycepin 및 adenosine의 함량은 표1에 나타냈다.In addition, the structural characteristics of CMWE using HPLC, and the presence of cordycepin and adenosine in CMWE were examined. As a result, CMWE was found to contain both cordycepin and adenosine because several peaks appeared at 3 to 10 minutes (FIG. 2) . The contents of cordycepin and adenosine contained in the CMWE are shown in Table 1.

[표 1][Table 1]

Figure pat00001

Figure pat00001

<< 실시예Example 2> 사람의 간암세포인  2> Human liver cancer cells HepG2HepG2 (( HumanHuman hepatomahepatoma cellcell lineline )와 정상세포인 ) And normal cells ChangChang (( HumanHuman liverliver cellcell lineline )의 배양) Culture

사람의 간암세포인 HepG2(Human hepatoma cell line)와 정상세포인 Chang(Human liver cell line)을 각각 한국 세포주 은행에서 구입하여 사용하고 cell배양은 DMEM(Dulbecco's modified Eagle's Medium)배지에 10% Fetal bovine serum(HyClone Labs, Logan, UT), 100units/mL penicilling, 100ug/mL streptomycin을 넣어 37℃, 5% CO2 incubator에서 배양하였다.HepG2 (human hepatoma cell line) and Chang (human liver cell line), which are normal cells, were purchased from Korean Cell Line Bank. Cell culture was performed in DMEM (Dulbecco's modified Eagle's Medium) supplemented with 10% fetal bovine serum (HyClone Labs, Logan, UT) , 100units / mL penicilling, 100ug / mL into the streptomycin 37 ℃, 5% CO 2 incubator.

<< 실시예Example 3>  3> CellCell ViabilityViability -  - MTTMTT assayassay

사람의 정상 간세포인 Chang cell line을 10% FBS가 첨가된 DMEM배지를 이용하여 96well plate에 각 well 당 1x104 cell 갯수로 하여 파종하고 24h 이후 1% FBS로 starvation한다.Normal human hepatocyte Chang cell line is seeded with 1 × 10 4 cells per well on a 96-well plate using DMEM supplemented with 10% FBS, and starvation is performed with 1% FBS after 24 h.

24hr 이후에 1% FBS 첨가 후 CMWE를 0, 12.5, 25, 50, 100 ㎍/㎖ 농도로 처리하고 30min 배양한다. 간독성 유발물질인 Sodium Nitroprusside(SNP) 600μM와 Acetaminophen(AAP) 15mMf를 각각 처리한다.After 24 h, 1% FBS was added, and CMWE was treated at 0, 12.5, 25, 50, 100 ㎍ / ㎖ and cultured for 30 min. Sodium Nitroprusside (SNP) 600μM and Acetaminophen (AAP) 15mMf are treated respectively.

배양 후 최종농도로 1mg/㎖의 MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide)시약을 넣어 2hr 배양시킨 후 형성된 formazan dye를 2-propanol을 이용하여 용해시켜 570nm 흡광도에서 측정하여 cell viability 정도를 측정하였다.
After incubation, MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl-tetrazolium bromide) reagent was added to the final concentration and the formazan dye formed was dissolved in 2-propanol . Cell viability was measured by measuring absorbance at 570 nm.

<< 실험예1Experimental Example 1 > 정상 간세포(> Normal hepatocytes ( NormalNormal cellcell )인 )sign ChangChang cellcell 에서의 In 번데기동충하초Pupae Cordyceps 추출물  extract CMWECMWE 의 효과 측정Effect measurement

번데기동충하초 추출물 CMWE가 정상 간 세포(Normal cell)인 Chang cell에 어떠한 작용을 일으키는지를 알아보기 위해, 번데기동충하초 추출물(CMWE)을 100, 200, 400, 800, 및 1000ug/mL의 농도에서 정상세포인 Chang cell에 처리하여 CMWE의 효과를 측정하였다.       In order to investigate the effect of CMWE on the normal cell, Chang cells, pupae Cordyceps sinensis extract (CMWE) was cultured in normal cells at 100, 200, 400, 800, and 1000 ug / Chang cells to measure the effect of CMWE.

실험결과, 도 4에서 보이는 바와 같이 48시간 및 72시간 배양하였을 때 정상세포에 큰 효과를 주지 않는다는 것이 나타났고 이것은 CMWE는 정상 간세포에 어떠한 저해작용을 주지 않는다는 결과를 나타내었으며 CMWE의 농도가 증가함에 따라 800, 1000ug/ml에서는 정상세포의 보호작용이 있음을 확인할 수 있었다.As shown in FIG. 4, when cultured for 48 hours and 72 hours, it was found that CMWE had no effect on normal cells, and CMWE showed no inhibitory effect on normal hepatocytes. Therefore, it was confirmed that normal cells were protected at 800 and 1000 ug / ml.

또한, 48시간 배양에 비해 72시간 배양에서는 cell viability가 약간 떨어지는 것을 알 수 있었다.In addition, cell viability was slightly lower in the 72 hr culture than in the 48 hr culture.

<< 실험예Experimental Example 2>  2> 번데기동충하초Pupae Cordyceps 추출물  extract CMWECMWE 의 간암세포(Of liver cancer cells HepG2HepG2 -- cellcell ) 억제효과 측정) Inhibition effect measurement

CMWE의 농도를 100, 200, 400, 800, 1000ug/mL의 농도를 간암세포인 HepG2 cell에 처리한 결과, 농도가 증가함에 따라 암세포의 Viability가 48시간 배양, 72시간 배양에서 감소하는 것을 확인할 수 있었고 400ug/ml 이상의 CMWE 농도첨가에 따라, 간암세포인 HepG2 cell에 효과가 있음을 확인하였다(도 5).
The concentration of CMWE was 100, 200, 400, 800, and 1000 ug / mL in HepG2 cells. As a result, the viability of the cancer cells decreased in 48 hours and 72 hours , And it was confirmed that the addition of CMWE concentration of 400 ug / ml or more was effective in HepG2 cell as a hepatic cancer cell (Fig. 5).

<      < 실험예Experimental Example 3> 저해제에 의한 정상세포( 3> normal cells by inhibitor ( ChangChang cellcell )의 손상 및 각각의 저해제의 IC50측정과 ) And the IC50 of each inhibitor and 번데기동충하초Pupae Cordyceps 추출물  extract CMWECMWE 의 보호 효과의 측정Measuring the protective effect of

대표적인 간기능 저해제(SNP, Acetoaminophen, ethanol)를 선택하여 정상세포(Chang cell) 의 손상을 번데기동충하초 추출물 CMWE가 보호해줄수 있는지를 발견하기 위하여, 정상세포의 손상을 주는 IC 50을 측정하였다. In order to find out whether a typical liver function inhibitor (SNP, Acetoaminophen, ethanol) could protect the Chang cell from damaging the pupa, CMWE of the pupa, we measured the IC 50 which damages the normal cell.

SNP에 의한 정상세포(Chang cell) 의 손상을 비교하기 위하여, 저해제로서의 SNP의 농도를 결정하기 위한 실험을 하였다,       In order to compare the damage of normal cells (Chang cells) by SNP, experiments were conducted to determine the concentration of SNP as an inhibitor,

0, 250, 500, 750, 1,000uM의 SNP의 농도를 정상세포인 Chang cell(1x104 cell/well)에 처리하였을 때, 619.3 uM에서, 50%의 cell viability의 감소를 나타냈다(도 6 및 도 7).When the concentration of SNPs of 0, 250, 500, 750, and 1,000 uM was treated in normal cells ( 1 x 10 4 cells / well), the cell viability decreased by 50% at 619.3 uM 7).

상기의 실험 결과, 619.3uM의 SNP 에서 50%의 cell viability의 감소를 나내는 결과를 보였으므로 600uM의 SNP에서 간세포(Chang cell)에 영향을 미치는 것으로 확인되었다. 따라서, 600uM의 SNP에서 대략 50-60%의 간 생존율 주는 것으로 재확인 되었다(도 8).        As a result, the cell viability was reduced by 50% at a SNP of 619.3 uM. Therefore, it was confirmed that 600 uM of SNP affects the hepatocyte (Chang cell). Thus, it was reaffirmed to give a liver survival rate of approximately 50-60% at a SNP of 600 uM (Fig. 8).

술(Ethanol)에 의한 정상세포(Chang cell) 의 손상을 비교하기 위하여, 저해제로서의 ethanol의 농도를 결정하기 위한 실험을 한 결과,         In order to compare the damage of normal cells (Chang cells) by ethanol, the concentration of ethanol as an inhibitor was determined.

0, 100, 200, 300, 400, 500 uM의 ethanol의 농도를 정상세포인 Chang cell(1x104 cell/well)에 처리하였을 경우, 514.5 uM에서, 50%의 cell viability의 감소를 나타내는 결과를 보였다(도 9 및 도 10).Cells treated with Chang cells (1 × 10 4 cells / well) at concentrations of 0, 100, 200, 300, 400 and 500 μM were reduced to 50% cell viability at 514.5 μM (Figs. 9 and 10).

상기의 실험 결과, 514.5 uM의 SNP 에서, 50%의 cell viability의 감소를 나타내는 결과를 보였으므로, 600uM의 SNP에서 간세포(Chang cell)에 영향을 미치는 것으로 확인되었다. 따라서, 500uM의 ethanol 농도에서 간세포(Chang cell) 손상은 70-80%의 간 생존율 주는 것으로 재확인 되었다(도 11).     As a result of the above experiment, it was confirmed that 50% cell viability was decreased at 514.5 uM SNP, and therefore it was confirmed that 600 uM SNP affects the hepatocyte (Chang cell). Thus, at 500 uM ethanol concentration, liver cell damage was reaffirmed to give a liver survival rate of 70-80% (Fig. 11).

AAP(Acetaminophen)에 의한 정상세포(Chang cell)의 손상을 비교하기 위하여, 저해제로서의 AAP의 농도를 결정하기 위한 실험을 한 결과,         In order to compare the damage of normal cells (Chang cells) by AAP (Acetaminophen), we conducted an experiment to determine the concentration of AAP as an inhibitor. As a result,

0, 5, 10, 20, 40 uM의 AAP 농도를 정상세포인 Chang cell(1x104 cell/well)에 처리하였을 경우, 10 uM 수준에서, 50%의 cell viability의 감소를 보이는 결과를 나타냈다(도 12 및 도 13).When the AAP concentration of 0, 5, 10, 20 and 40 μM was treated with Chang cells (1 × 10 4 cells / well), the cell viability was reduced by 50% at the level of 10 μM 12 and FIG. 13).

상기의 실험 결과, 10uM의 AAP에서 50%의 cell viability의 감소를 나타내는 결과를 보였으므로, 7.5uM 및 15uM의 AAP에서 간세포(Chang cell)에서의 영향을 미치는 것으로 확인되었다. 따라서, 7.5uM의 AAP에서는 간세포(Chang cell)에 대략 70%의 간 생존율 주는 것으로 재확인하였으며(도 14), 15uM의 AAP에서는 간세포(Chang cell)에 대략 20%의 간 생존율을 주는 것으로 나타났다(도 15).
As a result of the above experiment, 50% cell viability was reduced in 10 uM AAP. Therefore, it was confirmed that hepatocyte (Chang cell) affects 7.5 uM and 15 uM AAP. Thus, in 7.5 uM AAP, hepatocyte (Chang cell) was confirmed to have a hepatocyte survival rate of approximately 70% (Fig. 14) and 15 uM AAP hepatocyte (Chang cell) hepatocyte survival rate was approximately 20% 15).

<< 실험예Experimental Example 3>  3> 번데기동충하초Pupae Cordyceps 시료( sample( CMWECMWE )의 )of 간보호Liver protection 작용 기작 Action mechanism

번데기동충하초 추출물인 CMWE 가 정상 간 세포(Normal cell)인 Chang cell에 어떠한 작용을 일으키는지를 알아보기 위해, 번데기동충하초 추출물(CMWE)을 0, 12.5, 25, 50, 100, 200 ㎍/㎖의 농도를 정상세포인 Chang cell에 처리하여 CMWE의 효과를 확인하였다(도 16).         In order to investigate the effect of CMWE, a pupa extract of Chinese pupa, on the normal cell, Chang cells, pupa extracts of CMWE were cultured at 0, 12.5, 25, 50, 100 and 200 ㎍ / The effect of CMWE was confirmed by treatment with Chang cells, which is a normal cell (Fig. 16).

실험결과, 24시간 배양하였을 때, 정상세포에 어떠한 독성도 주지 않는다는 것을 나타내었고 이러한 결과는 CMWE가 정상 간세포에 어떠한 저해작용도 주지 않는다는 결과를 나타냈으며, CMWE의 농도가 낮은 12.5 및 25㎍/㎖에서는 정상세포의 보호작용이 있음을 확인하였다. 결론적으로, CMWE는 정상 간세포에 어떠한 저해작용을 주지 않는다는 결과를 확인하였다(도 16).
The results showed that CMWE did not give any inhibitory effect on normal hepatocytes. The results showed that CMWE was not toxic to normal cells at 12.5 and 25 ㎍ / ㎖ , It was confirmed that the cells had a protective action against normal cells. In conclusion, CMWE showed no inhibitory effect on normal hepatocytes (Fig. 16).

<< 실험예Experimental Example 4> 저해제( 4> Inhibitor ( AAPAAP , , SNPSNP )에 의한 정상세포() In normal cells ChangChang cellcell )의 손상 및 ) And 번데Bundata 기동충하초 추출물인 The extract CMWECMWE 의 보호 효과Protective effect of

저해제(APP, SNP)에 의해 정상세포인 간세포가 손상되었을 때 번데기동충하초 추출물인 CMWE가 간세포를 보호해줄 수 있는지를 실험하였다.       We investigated whether CMWE, a chrysanthemum Cordyceps sinensis extract, could protect hepatocytes when normal hepatocytes were damaged by inhibitors (APP, SNP).

APP를 정상세포인 Chang cell(1X104 cell/well)에 처리하였을 경우, AAP는 10uM 수준에서, 50%의 cell viability의 감소를 나타내는 결과를 보였다. 그러므로, AAP에 의한 간세포 손상과 번데기동충하초 추출물인 CMWE의 보호 작용을 실험하기 위하여, CMWE를 12.5, 25. 50, 100㎍/㎖을 각각 처리한 후, 저해제인 AAP를 10uM 처리하여 CMWE의 간세포 보호작용의 효과를 실험하였다.When APP was treated with normal cells (1 × 10 4 cells / well), AAP showed a decrease of cell viability of 50% at 10 μM level. Therefore, in order to test the protective effect of CMWE, a hepatocyte injury caused by AAP, and CMWE, a 12.5, 25.50, and 100 μg / ml of CMWE, The effect of the action was tested.

C(control-아무처리도 않은 간세포), C'(AAP 10uM 를 처리한 간세포)를 여러 CMWE를 처리한 group과 비교하였을 때, AAP 10uM 를 처리한 간세포 C' 보다는 높게 나타났으며, 이러한 결과는 AAP를 간세포에 처리하였을 때 보호효과가 있음을 나타내었다(도 17).  C (control-treated hepatocytes) and C '(hepatocytes treated with 10 μM AAP) were higher than hepatocyte C' treated with 10 μM AAP, compared to the groups treated with various CMWEs, AAP was shown to have a protective effect when treated with hepatocytes (Fig. 17).

상기의 실험에서, 정상세포인 Chang cell(1X104 cell/well)에 처리하였을 경우, SNP는 500uM 수준에서, 50%의 cell viability의 감소를 나타내는 결과를 보였으므로 SNP에 의한 간세포 손상과 번데기동충하초 추출물인 CMWE의 보호작용을 실험하기 위하여, CMWE를 12.5, 25. 50, 100㎍/㎖ 각각 처리한 후, 저해제인 SNP 600 uM 를 처리하여, CMWE의 간세포 보호작용을 실험하였다.In the above experiment, when treated with Chang cells (1 × 10 4 cells / well), the SNP decreased by 50% at the level of 500 μM. Therefore, hepatocyte injury by SNP and pupa extract of Cordyceps sinensis To investigate the protective effect of CMWE, CMWE was treated with 12.5, 25.50 and 100 μg / ml, respectively, and treated with 600 μM of SNP as an inhibitor.

C(control-아무처리도 않은 간세포), C'( SNP 600 uM 를 처리한 간세포)를 여러 CMW 처리한 group와 비교하였을 때, CMWE를 12.5 및 25㎍/㎖를 처리한 후, SNP 600uM를 처리한 group에서 SNP 600uM를 처리한 group C' 보다는 높게 나타났으며, 이러한 결과는 번데기동충하초 추출물(CMWE)에 저해제인 SNP로 간세포를 손상시켰을 때, 보호효과가 있음을 확인하였다(도 18).  When CMWE was treated with 12.5 and 25 μg / ml, the SNP was treated at 600 μM when C (control - untreated hepatocytes) and C '(hepatocytes treated with 600 uM SNPs) were compared with various CMW treated groups The results were higher than those of group C 'treated with 600 uM of SNP in one group. These results showed that when the hepatocyte was damaged by the inhibitor SNP in the pupa chrysanthemum extract (CMWE), it had a protective effect (FIG. 18).

< < 실시예Example 4> 간세포 손상에 대한 보호 효능의 생화학적 기전 규명 4> Identification of Biochemical Mechanism of Protection Effect on Hepatocyte Injury

번데기동충하초 추출물(CMWE)이 간세포 손상에 대한 보호 효능의 생화학적 기전을 규명하기 위하여 세포 사멸(apoptosis) 및 생존에 관여하는 세포신호전달 물질에 대해 propidium iodide 염색법을 이용한 Flow cytometry 분석과 Western blotting 방법으로 실험을 하였다.        Flow cytometry analysis and Western blotting method using propidium iodide staining for cell signaling substances involved in apoptosis and survival in order to elucidate the biochemical mechanism of the protective effect on the hepatocyte injury by the pupa extract of Chinese pupa (CMWE) Experiments were conducted.

<< 실험예Experimental Example 1>  1> FlowFlow cytometrycytometry 분석 analysis

AAP(Acetoaminophen)에 의한 Chang liver cell의 세포주기 변화를 측정하기 위하여 propidium iodide(PI) 염색법을 수행하였다. 우선 Chang liver cell을 100mm dish에 70~80% 되도록 배양한 후, 번데기동충하초 추출물(CMWE)과 AAP를 처리하고 24hr 배양하였다. 세포를 PBS로 2회 세척한 후 trypsin/EDTA로 떼어내고 450 x g에서 5min 동안 원심분리하여 회수하였다. 세포를 1x106 cells/이 되도록 PBS를 넣고, 5ml의 1%(w/v in PBS) paraformaldehyde 용액을 넣고 ice bath에 15min 방치하였다. 450 x g에서 5min 동안 원심분리하여 세포를 회수하고, PBS로 5ml로 2회 반복하여 세척하였다. 원심분리하여 얻은 세포에 0.5ml의 PBS를 넣고 5ml의 ice-cold 70%(v/v) ethanol을 넣고 -20℃ 이하에서 12hr 이상 방치하였다. 세포를 450 x g에서 5min 동안 원심분리하여 ethanol을 제거한 후, PBS 1ml로 세척하고 다시 PBS 0.1ml을 넣어 부유시켰다. 세포 부유액에 PI는 50㎍/㎖, DNase-free RNase는 1㎍/㎖의 최종 농도가 되도록 첨가하고 호일로 감싸 빛을 차단 한 후 30min 동안 염색을 시켰다. PI 염색된 세포를 filter하여 단일 세포만을 취해 FACS Calibur(Becton Dickinson, San Jose, CA)로 1x104개의 세포를 분석하였다.Propidium iodide (PI) staining was performed to measure cell cycle changes of Chang liver cell by AAP (Acetoaminophen). First, Chang liver cells were cultured in 100 mm dish at 70 ~ 80%, and then cultured with pupa extract (CMWE) and AAP for 24 hours. Cells were washed twice with PBS and then trypsin / EDTA and centrifuged at 450 xg for 5 min. Cells were plated at 1 × 10 6 cells / well, and 5 ml of 1% (w / v in PBS) paraformaldehyde solution was added and left in the ice bath for 15 min. Cells were harvested by centrifugation at 450 xg for 5 min, washed twice with 5 ml PBS. After centrifugation, 0.5 ml of PBS was added to the cells, and 5 ml of ice-cold 70% (v / v) ethanol was added thereto. The cells were centrifuged at 450 xg for 5 min to remove ethanol, washed with 1 ml of PBS, and then suspended with 0.1 ml of PBS. 50 μg / ml of PI was added to the cell suspension, DNase-free RNase was added to a final concentration of 1 μg / ml, and the mixture was covered with foil to block light and stained for 30 min. The PI-stained cells were filtered to take single cells and analyzed 1x10 4 cells with FACS Calibur (Becton Dickinson, San Jose, Calif.).

실험결과는 도 19, 도 20에 나타난 바와 같이 정상 간세포에 7mM AAP를 처리하면 세포주기에서 G2/M기가 감소하고 Sub-G1기가 증가하는 것을 관찰할 수 있으며, 이러한 Sub-G1기의 증가는 세포의 apoptosis 과정에서 특징적으로 나타나는 현상으로 알려져 있다. 또한, AAP에 의해 증가된 Sub-G1기는 CMWE의 병행투여에 의해 농도 의존적으로 감소하는 경향을 보였다. 이러한 결과는 도 20.B에서 보다 자세하게 나타난다. 도 20.B에서 Control 그룹의 Sub-G1기는 2.35%이고, 7mM AAP의 투여에 의해 12.37%로 증가되는 것을 관찰할 수 있었다. 또한, CMWE 각각의 최종 농도가 50, 100, 200/가 되도록 AAP와 병행투여 했을 때 Sub-G1기가 11.86%, 10.4%, 7.8%로 감소하고 CMWE의 농도도 의존적으로 감소되어 세포사멸을 막아주는 것을 관찰할 수 있었다.        As shown in FIG. 19 and FIG. 20, when 7 mM AAP was applied to normal hepatocytes, the G2 / M group decreased and the Sub-G1 group increased in the cell cycle, Is known to be a characteristic feature of apoptosis process. In addition, the Sub-G1 phase increased by AAP tended to decrease in a concentration-dependent manner by the concurrent administration of CMWE. These results are shown in more detail in Fig. 20B. In Fig. 20B, the Sub-G1 period of the Control group was 2.35%, which was increased to 12.37% by the administration of 7 mM AAP. The concentration of CMWE decreased to 11.86%, 10.4%, and 7.8%, respectively, when the final concentration of CMWE was 50, 100, 200 / .

이러한 결과는, 정상 간세포에서 AAP에 의해 유도된 세포 독성, 즉 세포주기의 정지(cell cycle arrest)와 세포사멸에 대해 번데기동충하초 추출물(CMWE)이 간세포 보호활성이 있음을 보여주고 있다.
These results show that AAP-induced cytotoxicity, that is, cell cycle arrest and cell death induced by hepatocyte growth factor (CMWE) in normal hepatocytes, have hepatocyte protective activity.

<< 실험예Experimental Example 2>  2> WesternWestern blottingblotting 분석 analysis

정상 간세포인 Chang liver cell을 60mm dish에서 70~80%가 되도록 배양한 후, 1% FBS가 들어있는 배지로 24hr 배양하였다. Chang liver cell에 번데기동충하초 추출물(CMWE)을 일정 농도로 투여하고, 30분 후에 간독성 유발물질인 AAP를 투여하였다. 24hr 배양한 후 lysis buffer를 넣어 세포를 용해시키고, 15,000g에서 20분간 원심분리하여 western blot 시료를 얻어냈다. BCA법으로 세포 lysate의 단백질 농도를 측정하여, 30㎍의 단백질이 되도록 세포 lysate를 취해 SDS-PAGE를 실행하였다. PVDF membrane으로 단백질을 transfer 시킨 후, 5% non-fat skim milk를 사용해 membrane을 blocking시키고, 원하는 항체 용액을 사용해 1차 처리하고, TBS-T로 washing한 후 2차 항체를 붙였다. 최대한 TBS-T로 붙지 않은 항체를 씻어주고, 암실에서 membrane에 ECL 용액 (Thermo Scientific, Rockford, IL)을 골고루 분주하여 X-ray film으로 감광하였다. Western blot 결과는 NIH(National Institutes of Health, USA)에서 개발한 Image J 프로그램을 이용하여 분석하였다. Image J에 의한 분석은 3회 반복하여 얻은 값의 평균값을 사용하였다.       Chang liver cells, normal hepatocytes, were cultured in a 60 mm dish at 70-80%, and then cultured in a medium containing 1% FBS for 24 hours. Chang liver cell extract (CMWE) was administered at a certain concentration, and 30 minutes later, AAP, a hepatotoxic inducer, was administered. After incubation for 24 hours, the cells were lysed by adding lysis buffer and centrifuged at 15,000 g for 20 minutes to obtain a western blot sample. The protein concentration of the cell lysate was measured by the BCA method, and the cell lysate was subjected to SDS-PAGE to be 30 μg of the protein. After transferring the protein to PVDF membrane, the membrane was blocked with 5% non-fat skim milk, first treated with the desired antibody solution, washed with TBS-T, and attached with secondary antibody. As much as possible, TBS-T unbound antibody was washed and ECL solution (Thermo Scientific, Rockford, Ill.) Was evenly distributed on the membrane in the dark room and sensitized with X-ray film. Western blot analysis was performed using the Image J program developed by NIH (National Institutes of Health, USA). For the analysis by Image J, the average value obtained by repeating 3 times was used.

실험결과, 도 21에 나타난 바와 같이 7mM AAP(3 lane)에 의해 활성화된 PARP의 양이 늘어난 것을 확인할 수 있었고, CMWE의 병행 투여에 의해 활성화된 PARP 양이 감소 되는 것으로 나타났다. 또한, CMWE에 함유되어 있는 cordycepin에 대해서도 각각 10, 20, 50, 100μM로 AAP와 병행 투여했을 때에도 CMWE와 유사한 패턴을 보였고, cordycepin 농도에 의존적으로 활성화된 PARP 양이 감소된 것으로 나타났다.      As a result, it was confirmed that the amount of PARP activated by 7 mM AAP (3 lane) was increased as shown in FIG. 21, and the amount of PARP activated by the CMWE administration was decreased. In addition, CMWE-induced cordycepin also showed patterns similar to CMWE when administered concurrently with AAP at 10, 20, 50, and 100 μM, respectively, and the amount of activated PARP was decreased in response to cordycepin concentration.

이러한 CMWE 및 cordycepin의 병행투여에 의해 세포사멸의 마지막 단계에서 작용하는 활성화된 PARP의 감소된 결과는, 세포독성에 의한 신호전달과정의 초기에 CMWE 및 cordycepin이 세포독성을 감소시키는 역할을 하였고, 이로 인해 PARP 활성이 낮아진 것으로 확인되었다.  The reduced results of activated PARP acting at the last stage of apoptosis by the combined administration of CMWE and cordycepin showed that CMWE and cordycepin reduced cytotoxicity at the early stage of cytotoxic signal transduction, PARP activity was decreased.

또한, 세포의 생존과 증식에 관여하는 신호전달 단백질로 알려져 있는 ERK에 대해, CMWE 및 cordycepin이 ERK 단백질의 활성에 영향을 주는지 실험을 진행하였다. 실험결과, 도 22에서 나타난 바와 같이, 세포독성 유발물질인 7mM AAP의 투여에 의해 ERK의 활성(p-ERK)이 감소된 것을 관찰할 수 있었다. CMWE 및 cordycepin의 병행투여에 의해서는 p-ERK의 양이 다소 증가하는 경향을 보였지만 확연한 증가는 관찰되지 않았다. 그렇지만, 도 22.B에서와 같이 세포의 양에 대한 활성화된 ERK 양(p-ERK/-actin)의 비를 확인하면, CMWE 및 cordycepin의 농도도 p-ERK 양이 증가하는 것을 확인할 수 있었다.        In addition, we investigated whether CMWE and cordycepin affect the activity of ERK protein, ERK, which is known as a signal transduction protein involved in cell survival and proliferation. As shown in FIG. 22, the activity of ERK (p-ERK) was decreased by the administration of 7 mM AAP, a cytotoxic inducer. The concurrent administration of CMWE and cordycepin showed a slight increase in the amount of p-ERK, but no significant increase was observed. However, when the ratio of the amount of activated ERK (p-ERK / -actin) to the amount of cells as shown in Fig. 22B was confirmed, it was confirmed that the amount of p-ERK also increased in the concentration of CMWE and cordycepin.

즉, 정상 간세포에서 세포독성이 유발되었음에도 CMWE 및 cordycepin의 투여에 의해 세포의 생존 및 증식에 관여하는 p-ERK의 증가는, CMWE 및 cordycepin이 세포독성으로부터 간세포를 보호하는 생리활성효과가 있음을 간접적으로 보여주고 있다.  In other words, the increase of p-ERK, which is involved in the survival and proliferation of the cells by administration of CMWE and cordycepin, despite the induction of cytotoxicity in normal hepatocytes, suggests that CMWE and cordycepin have a physiological activity effect for protecting hepatocytes from cytotoxicity .

두 번째로, 세포에 활성 산소종이나 염증성 cytokine, UV 등의 물리화학적 외부 스트레스에 의해 활성화되는 JNK와 p38 단백질에 대해 Western blot 실험(도 23)을 수행하였다.         Second, Western blot experiments (FIG. 23) were performed on JNK and p38 proteins activated by physiochemical external stresses such as reactive oxygen species, inflammatory cytokine, and UV in cells.

도 23.A에서와 같이 7mM AAP에 의해 세포독성이 유도되면 Control 그룹에 비해 JNK의 활성(p-JNK)이 증가되고, p38의 활성(p-p38)은 다소 감소되는 것을 관찰할 수 있었다. 독성유발 물질인 AAP와 CMWE를 병행 투여했을 때, 낮아진 p38 활성은 Control 그룹 수준으로 회복되지는 않았지만, 증가된 JNK 활성은 CMWE의 농도 의존적으로 낮아지는 것을 관찰할 수 있었다.  As shown in FIG. 23A, when cytotoxicity was induced by 7 mM AAP, the activity of JNK (p-JNK) was increased and the activity of p38 (p-p38) was slightly decreased compared with that of the control group. When combined with AAP and CMWE, the lowered p38 activity did not recover to the level of the control group, but the increased JNK activity was observed to be dependent on the concentration of CMWE.

CMWE에 의한 JNK의 활성 변화는 도 23.B에서와 같이, 동일한 세포에 대한 활성화된 JNK의 비(p-JNK/-actin)를 확인해 보면, 세포독성 의해 증가 된 JNK의 활성이 CMWE의 병행투여에 의해 농도의존적으로 Control 그룹과 같은 수준으로 감소되는 것을 확인할 수 있었다.  As shown in FIG. 23B, when the ratio of activated JNK (p-JNK / -actin) to the same cell was examined, the activity of JNK increased by cytotoxicity was increased by CMWE And the concentration was decreased to the same level as that of the control group.

Claims (4)

건조한 번데기동충하초 분쇄물을 10배의 증류수에 넣어 열수출하고 여과한 다음 2배 용량의 주정에 혼합하고 방치한 다음 원심분리하여 얻은 침전물을 증류수로 용해한 후 동결건조하는 것이 특징인 동충하초 추출물(CMWE)의 제조방법.       (CMWE), which is characterized by dissolving the precipitate obtained by centrifuging the distilled water, and lyophilizing the precipitate obtained by centrifuging the dried pupa extract of the Chinese pupa, 10 times of distilled water, &Lt; / RTI &gt; 제 1항의 방법에 따라 제조된 간기능 개선용 번데기동충하초 추출물A pupa extract of a pupa for improving liver function produced according to the method of claim 1 제 1항 기재의 방법에 따라 제조된, 번데기동충하초 추출물 유래의 코디세핀(Cordycepin)과 아데노신(Adenosine)을 함유하는 것을 특징으로 하는 간암 예방 및 치료용 약학적 조성물.A pharmaceutical composition for preventing and treating liver cancer, which comprises Cordycepin and Adenosine derived from a pupa chrysanthemum extract prepared according to the method of claim 1. 제 1항 기재의 방법에 따라 제조된, 번데기동충하초 추출물 유래의 코디세핀(Cordycepin)과 아데노신(Adenosine)을 유효성분으로 함유하는 것을 특징으로 하는 간기능 개선 기능성 식품 조성물.

A functional food composition for functional improvement of liver function characterized by comprising cordycepin and adenosine derived from a pupa chrysanthemum extract prepared according to the method of claim 1 as an active ingredient.

KR1020130088704A 2013-07-26 2013-07-26 Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method KR20150014033A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130088704A KR20150014033A (en) 2013-07-26 2013-07-26 Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130088704A KR20150014033A (en) 2013-07-26 2013-07-26 Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method

Publications (1)

Publication Number Publication Date
KR20150014033A true KR20150014033A (en) 2015-02-06

Family

ID=52570988

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130088704A KR20150014033A (en) 2013-07-26 2013-07-26 Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method

Country Status (1)

Country Link
KR (1) KR20150014033A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101908862B1 (en) * 2017-10-26 2018-10-16 (주)세포활성연구소 Method for manufacturing fermented Cordyceps militaris extract grown on Rhynchosia Nulubilis Soybean and its use for prevention and treatment of non-alcoholic fatty liver disease
CN109406673A (en) * 2018-11-26 2019-03-01 江西省药明扬海医药科技有限公司 A kind of fingerprint atlas detection method of paecilomyces hepiall chen
KR101962893B1 (en) * 2017-11-24 2019-03-27 순천대학교 산학협력단 Composition of comprising vegetable worms extract cultured using mealworm or pupa and process of fabrication the extract
KR102137515B1 (en) 2020-02-07 2020-07-24 주식회사 바이오텍에스알에스 Composition for improving liver and brain function comprising cordycepin and phospholipid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101908862B1 (en) * 2017-10-26 2018-10-16 (주)세포활성연구소 Method for manufacturing fermented Cordyceps militaris extract grown on Rhynchosia Nulubilis Soybean and its use for prevention and treatment of non-alcoholic fatty liver disease
KR101962893B1 (en) * 2017-11-24 2019-03-27 순천대학교 산학협력단 Composition of comprising vegetable worms extract cultured using mealworm or pupa and process of fabrication the extract
CN109406673A (en) * 2018-11-26 2019-03-01 江西省药明扬海医药科技有限公司 A kind of fingerprint atlas detection method of paecilomyces hepiall chen
KR102137515B1 (en) 2020-02-07 2020-07-24 주식회사 바이오텍에스알에스 Composition for improving liver and brain function comprising cordycepin and phospholipid

Similar Documents

Publication Publication Date Title
Teixeira da Silva et al. The medicinal and pharmaceutical importance of Dendrobium species
KR101074158B1 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
CN113244296B (en) Medicinal volatile oil composition and preparation method and application thereof
JP2002541204A (en) Pharmaceutical formulation useful for treating hepatitis B, hepatitis C and other liver related virus infections and method for preparing the same
KR20150014033A (en) Food composition for liver activity contaning Water extract of Cordyceps militaris and its manufacturing method
KR101181321B1 (en) Composition for allergy improvement containing zizania latifolia extracts
CN106632614A (en) Periplaneta americana immunomodulating peptide and preparation method and medical application thereof
CN105017438B (en) A kind of Radix et Rhizoma Gynurae divaricatae polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food
CN101019893A (en) Process of enriching effective antitumor part of periplaneta americana with polyamide
CN108686045A (en) A kind of callicarpa nudiflora composition and its application for treating pharyngitis
CN101099566A (en) Lactucin and its preparation method and application
CN109045035A (en) Application of 7- (2,2- dimethyl -3- crotonoyl the amido)-octahydro benzene quinoline acetic acid esters in preparation treatment liver disease drug
CN107669565A (en) A kind of natural antibacterial bath foam containing radix glycyrrhizae
Okokon et al. Antimalarial and analgesic activities of ethanolic leaf extract of Panicum maximum
Subramoniam et al. Inhibition of antigen-induced degranulation of sensitized mast cells by Trichopus zeylanicus in mice and rats
Ayoade et al. Composition of some traditional malaria remedies and their antiplasmodial effects on (Plasmodium berghei)
KR102181220B1 (en) Pharmaceutical composition for anti-cancer containing medicinal gerb extracts
CN103638052A (en) Polyrhachis dives extractive, and preparation and medical purpose thereof
Sevastre et al. Comparison of antitumor effect in two Viscum album L. extracts.
CN102697800B (en) Herba stellariae mediae polysaccharide composition and the application in preparation antiviral drugs thereof
CN101711790A (en) Wild Juglans mandshurica bark water extract used for curing liver cancer
Cui et al. Antitumor and immunoregulation effects and mechanism of n-butanol fraction from Zanthoxylum avicennae in H22 mice
Masevhe Isolation and characterization of antifungal compounds from Clerodendron glabrum var glabrum (Verbenaceae) used traditionally to treat candidiasis in Venda, South Africa
KR100726006B1 (en) Pharmaceutical composition comprising polysaccharides from Angelica gigas Nakai for inhibition of cancer metastasis
TWI741190B (en) Cordyceps militaris compound for improving respiratory diseases

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application